These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 27866656)

  • 21. CRISPRtools: a flexible computational platform for performing CRISPR/Cas9 experiments in the mouse.
    Peterson KA; Beane GL; Goodwin LO; Kutny PM; Reinholdt LG; Murray SA
    Mamm Genome; 2017 Aug; 28(7-8):283-290. PubMed ID: 28280930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole genome analysis of CRISPR Cas9 sgRNA off-target homologies via an efficient computational algorithm.
    Zhou H; Zhou M; Li D; Manthey J; Lioutikova E; Wang H; Zeng X
    BMC Genomics; 2017 Nov; 18(Suppl 9):826. PubMed ID: 29219081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using the CRISPR/Cas9 system to understand neuropeptide biology and regulation.
    Hay EA; Knowles C; Kolb A; MacKenzie A
    Neuropeptides; 2017 Aug; 64():19-25. PubMed ID: 28038787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TEAD4 regulates trophectoderm differentiation upstream of CDX2 in a GATA3-independent manner in the human preimplantation embryo.
    Stamatiadis P; Cosemans G; Boel A; Menten B; De Sutter P; Stoop D; Chuva de Sousa Lopes SM; Lluis F; Coucke P; Heindryckx B
    Hum Reprod; 2022 Jul; 37(8):1760-1773. PubMed ID: 35700449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9.
    Li J; Shou J; Guo Y; Tang Y; Wu Y; Jia Z; Zhai Y; Chen Z; Xu Q; Wu Q
    J Mol Cell Biol; 2015 Aug; 7(4):284-98. PubMed ID: 25757625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage.
    Riesenberg S; Helmbrecht N; Kanis P; Maricic T; Pääbo S
    Nat Commun; 2022 Jan; 13(1):489. PubMed ID: 35078986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSC software corrects off-target mediated gRNA depletion in CRISPR-Cas9 essentiality screens.
    Perez AR; Sala L; Perez RK; Vidigal JA
    Nat Commun; 2021 Nov; 12(1):6461. PubMed ID: 34753924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of CRISPR/Cas9 genome editing for loss-of-function in the early chick embryo.
    Gandhi S; Piacentino ML; Vieceli FM; Bronner ME
    Dev Biol; 2017 Dec; 432(1):86-97. PubMed ID: 29150011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cas9 Cuts and Consequences; Detecting, Predicting, and Mitigating CRISPR/Cas9 On- and Off-Target Damage: Techniques for Detecting, Predicting, and Mitigating the On- and off-target Effects of Cas9 Editing.
    Newman A; Starrs L; Burgio G
    Bioessays; 2020 Sep; 42(9):e2000047. PubMed ID: 32643177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9-Mediated Gene Knockout and Knockin Human iPSCs.
    Petazzi P; Menéndez P; Sevilla A
    Methods Mol Biol; 2022; 2454():559-574. PubMed ID: 33190185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9.
    Singh K; Evens H; Nair N; Rincón MY; Sarcar S; Samara-Kuko E; Chuah MK; VandenDriessche T
    Mol Ther; 2018 May; 26(5):1241-1254. PubMed ID: 29599079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells.
    Donohoue PD; Pacesa M; Lau E; Vidal B; Irby MJ; Nyer DB; Rotstein T; Banh L; Toh MS; Gibson J; Kohrs B; Baek K; Owen ALG; Slorach EM; van Overbeek M; Fuller CK; May AP; Jinek M; Cameron P
    Mol Cell; 2021 Sep; 81(17):3637-3649.e5. PubMed ID: 34478654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-Cas "Non-Target" Sites Inhibit On-Target Cutting Rates.
    Moreb EA; Hutmacher M; Lynch MD
    CRISPR J; 2020 Dec; 3(6):550-561. PubMed ID: 33346713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-Cas9 mediated gene deletions in lager yeast Saccharomyces pastorianus.
    Gorter de Vries AR; de Groot PA; van den Broek M; Daran JG
    Microb Cell Fact; 2017 Dec; 16(1):222. PubMed ID: 29207996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. multicrispr: gRNA design for prime editing and parallel targeting of thousands of targets.
    Bhagwat AM; Graumann J; Wiegandt R; Bentsen M; Welker J; Kuenne C; Preussner J; Braun T; Looso M
    Life Sci Alliance; 2020 Nov; 3(11):. PubMed ID: 32907859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly efficient targeted chromosome deletions using CRISPR/Cas9.
    He Z; Proudfoot C; Mileham AJ; McLaren DG; Whitelaw CB; Lillico SG
    Biotechnol Bioeng; 2015 May; 112(5):1060-4. PubMed ID: 25362885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-Directed Genome Knockout in Chicken Cell Line and Embryos Can Use CRISPR/Cas Gene Editing Technology.
    Zuo Q; Wang Y; Cheng S; Lian C; Tang B; Wang F; Lu Z; Ji Y; Zhao R; Zhang W; Jin K; Song J; Zhang Y; Li B
    G3 (Bethesda); 2016 Jun; 6(6):1787-92. PubMed ID: 27172204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A large-scale whole-genome sequencing analysis reveals highly specific genome editing by both Cas9 and Cpf1 (Cas12a) nucleases in rice.
    Tang X; Liu G; Zhou J; Ren Q; You Q; Tian L; Xin X; Zhong Z; Liu B; Zheng X; Zhang D; Malzahn A; Gong Z; Qi Y; Zhang T; Zhang Y
    Genome Biol; 2018 Jul; 19(1):84. PubMed ID: 29973285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.